<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To demonstrate the strong association of <z:e sem="disease" ids="C1167667" disease_type="Disease or Syndrome" abbrv="">diabetic mastopathy</z:e> or sclerosing lymphocytic lobulitis with type 1 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> by studying appropriate control groups and to describe risk factors and natural history of the disorder </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: This was a retrospective cross-sectional study of four groups of patients conducted at a setting tertiary care medical center </plain></SENT>
<SENT sid="2" pm="."><plain>We examined benign breast biopsies (investigator masked to identity) from age-matched patients with types 1 and 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, autoimmune <z:hpo ids='HP_0000820'>thyroid disease</z:hpo>, or none of the above disorders for sclerosing lymphocytic lobulitis </plain></SENT>
<SENT sid="3" pm="."><plain>Several risk factors proposed for the disorder (age at diagnosis of benign <z:e sem="disease" ids="C0006145" disease_type="Disease or Syndrome" abbrv="">breast disease</z:e>, duration of <z:mp ids='MP_0002055'>diabetes</z:mp>, age at <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:mp ids='MP_0002055'>diabetes</z:mp>, prevalence of <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e>, <z:hpo ids='HP_0000112'>nephropathy</z:hpo> and cheiroarthropathy, glycemic control, parity, oral contraceptive use, menopausal status, or number of breast biopsies) were evaluated, and patients were contacted to describe the natural history of the disorder </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Sclerosing lymphocytic lobulitis was identified in 69.7% of the subjects with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> and 1.8% of those with autoimmune <z:hpo ids='HP_0000820'>thyroid disease</z:hpo> diagnosed with benign <z:e sem="disease" ids="C0006145" disease_type="Disease or Syndrome" abbrv="">breast disease</z:e> at surgery </plain></SENT>
<SENT sid="5" pm="."><plain>It did not occur in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> with or without insulin treatment or in control subjects </plain></SENT>
<SENT sid="6" pm="."><plain>Only <z:hpo ids='HP_0000488'>retinopathy</z:hpo> and <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo> were associated with sclerosing lymphocytic lobulitis </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0003002'>Breast carcinoma</z:hpo> or <z:hpo ids='HP_0002665'>lymphoma</z:hpo> did not occur subsequently in any type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> patient with or without sclerosing lymphocytic lobulitis </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Sclerosing lymphocytic lobulitis is strongly associated with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000488'>Retinopathy</z:hpo> and <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> are associated with the disorder </plain></SENT>
<SENT sid="10" pm="."><plain>The risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> is not increased </plain></SENT>
</text></document>